Global Circulating Tumor Cells Market Report 2024

Circulating Tumor Cells Global Market Report 2024 – By Product (Kits And Reagents, Blood Collection Tubes, Devices Or Systems), By Technology (CTC Enrichment, CTC Detection, CTC Analysis), By Specimen (Blood, Bone Marrow, Other Body Fluids), By Application (Clinical Or Liquid Biopsy, Research) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Circulating Tumor Cells Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Circulating Tumor Cells Market Definition And Segments

Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.

The main products of circulating tumor cells include kits and reagents, blood collection tubes and devices or systems. Kits and reagents are a complete set of consumables that include a blood specimen separator, proprietary microfluidic capture chip, CTC enrichment, and immunostaining reagents. They are collected using different specimens of a human body including blood, bone marrow and other body fluids by using different technologies such as CTC enrichment, CTC detection and CTC analysis that are used for clinical or liquid biopsy and research applications.

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $10.79 billion in 2023 to $12.21 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to cancer incidence and prevalence, clinical utility in cancer staging, emergence of liquid biopsy, patient demand for minimally invasive tests, regulatory support for liquid biopsies, focus on early cancer detection.

The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $19.45 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to point-of-care CTC testing, adoption of microfluidics, focus on rare cancer types, standardization of CTC assays, expansion of CTC-based clinical trials, economic and emerging market growth. Major trends in the forecast period include innovations in CTC isolation techniques, government funding for CTC research, advancements in CTC detection technologies, liquid biopsy for cancer monitoring, integration with single-cell analysis, technological convergence with artificial intelligence (AI).

Rising Cancer Incidence Drives Surge In Circulating Tumor Cells Market

The growing incidence of cancer is expected to propel the circulating tumor cells market growth going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. Circulating tumor cells are used to help in the early detection and diagnosis of cancer, and thus growing incidence of cancer propels the growth of the circulating tumor cells market For instance, in January 2023, according to reports shared by the American Cancer Society Inc., a US-based voluntary health organization, by 2021, 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths. Therefore, the growing incidence of cancer is driving the growth of the circulating tumor cells market.

Rising Adoption Of Circulating Tumor Cells In Clinical Trials Is A Catalyst For Market Growth

The increasing adoption in clinical trials is expected to propel the growth of the circulating tumor cells market growth going forward. Clinical trials are research studies conducted to evaluate the safety, efficacy, and effectiveness of new medical treatments, interventions, or procedures in humans. The integration of circulating tumor cells (CTC) analysis in clinical trials enhances the ability to assess treatment response, early detection and monitoring, tailor interventions to specific patient profiles, and improve the overall efficiency and to validate clinical endpoints. For instance, in May 2023, according to Xtalks, a Canada-based company specializing in providing life science webinars and virtual events, there are 452,604 clinical studies that have been registered on ClinicalTrials.gov as of May 17, 2023. 64,838 studies out of the total number that have been registered are actively seeking participants which is an increase of 365,000 registered trials in 2021. Therefore, the increasing adoption in clinical trials is driving the growth of the circulating tumor cells market.

Major companies operating in the circulating tumor cells market report are Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd. .

The Surge Of Product Innovations In The Circulating Tumor Cells Market

Product innovations are a key trend gaining popularity in the circulating tumor cells market. Major companies operating in the circulating tumor cells market are focused on developing innovative products to strengthen their position in the market. For instance, in February 2021, Menarini Silicon Biosystems, an Italy-based company operating in liquid biopsy and single-cell technologies, launched the new CellMag CTC Epithelial Cell kit. The kit uses ferrofluid technology to streamline the manual immuno-magnetic enrichment and staining of rare CTCs (circulating tumor cells). It is a cost-effective and simple protocol for liquid biopsy labs by allowing standardization of sample preparation.

Increasing Focus On Liquid Biopsy Products To Provide Reliable Services To Their Customers

Major companies operating in the circulating tumor cells market are focusing on innovative products such as oncology liquid biopsy products to drive revenues in their market. Liquid biopsy in oncology refers to a minimally invasive or non-invasive technique used to identify and track disease biomarkers in bodily fluids such as sputum, blood, and urine. For instance, in June 2022, BillionToOne Inc., a US-based biotech company specializing in molecular diagnostics, launched oncology liquid biopsy products, NorthStar Select and NorthStar Response. NorthStar Select is a thorough somatic mutation profiling panel for cancer. The panel identifies actionable mutations with a noteworthy limit of detection because of BillionToOne's exclusive molecular counting method, known as quantitative counting templates (QCTs). NorthStar Response is a tissue-neutral, methylation-based treatment response monitoring test. The assay gives an exact estimate of the burden of methylation circulating tumor DNA (ctDNA) using molecular counting technologies.

Agilent Technologies Enhances Cancer Diagnostics Portfolio With Acquisition Of Resolution Bioscience Inc.

In April 2021, Agilent Technologies Inc., a US-based provider of software, instruments, and services for laboratory workflow, acquired Resolution Bioscience Inc. for an undisclosed amount. Through this acquisition, Agilent expands and strengthens its capabilities in cancer diagnostics and provides innovative technology to serve the medicine market. Resolution Bioscience, Inc. is a US-based developer of next-generation sequencing-based oncology solutions.

North America was the largest region in the circulating tumor cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the circulating tumor cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The circulating tumor cells market consists of sales of clinical samples, KRT7, PSMA positive cells, and TTF-1 positive. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The circulating tumor cells market research report is one of a series of new reports from The Business Research Company that provides circulating tumor cells market statistics, including circulating tumor cells industry global market size, regional shares, competitors with a circulating tumor cells market share, detailed circulating tumor cells market segments, market trends and opportunities, and any further data you may need to thrive in the circulating tumor cells industry. This circulating tumor cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Circulating Tumor Cells Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $12.21 billion
Revenue Forecast In 2033 $19.45 billion
Growth Rate CAGR of 12.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Precision Medicine Group LLC; Bio-Techne Corporation; BIOCEPT Inc.; Creativ MicroTech Inc.; Fluxion Biosciences Inc.; Ikonisys Inc.; Qiagen N.V.; ScreenCell SAS; STEMCELL Technologies Inc.; Sysmex Corporation; Aviva Biosciences Corporation; LungLife AI Inc.; Miltenyi Biotec GmbH; Menarini Silicon Biosystems S.p.A.; Canopus Bioscience Ltd.; IVDiagnostics Inc.; BioFluidica Inc.; Biolidics Limited; Rarecells Diagnostics SAS; LineaRx Inc.; Thermo Fisher Scientific Inc.; Greiner Bio-One International GmbH; Stanford Research Institute International; Agilent Technologies Inc.; Resolution Bioscience Inc.; Cynvenio Biosystems Inc.; ApoCell Inc.; Clearbridge BioMedics Pte. Ltd.; Celsee Inc.; RareCyte Inc.; On-chip Biotechnologies Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Circulating Tumor Cells Market Characteristics

    3. Circulating Tumor Cells Market Trends And Strategies

    4. Circulating Tumor Cells Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Circulating Tumor Cells Market Size and Growth

    5.1. Global Circulating Tumor Cells Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Circulating Tumor Cells Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Circulating Tumor Cells Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Circulating Tumor Cells Market Segmentation

    6.1. Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Kits And Reagents

    Blood Collection Tubes

    Devices Or Systems

    6.2. Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    CTC Enrichment

    CTC Detection

    CTC Analysis

    6.3. Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Blood

    Bone Marrow

    Other Body Fluids

    6.4. Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Clinical Or Liquid Biopsy

    Research

    7. Circulating Tumor Cells Market Regional And Country Analysis

    7.1. Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Circulating Tumor Cells Market  

    8.1. Asia-Pacific Circulating Tumor Cells Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Circulating Tumor Cells Market  

    9.1. China Circulating Tumor Cells Market Overview  

    9.2. China Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Circulating Tumor Cells Market  

    10.1. India Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Circulating Tumor Cells Market  

    11.1. Japan Circulating Tumor Cells Market Overview  

    11.2. Japan Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Circulating Tumor Cells Market  

    12.1. Australia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Circulating Tumor Cells Market  

    13.1. Indonesia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Circulating Tumor Cells Market  

    14.1. South Korea Circulating Tumor Cells Market Overview  

    14.2. South Korea Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Circulating Tumor Cells Market  

    15.1. Western Europe Circulating Tumor Cells Market Overview

    15.2. Western Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Circulating Tumor Cells Market  

    16.1. UK Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Circulating Tumor Cells Market  

    17.1. Germany Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Circulating Tumor Cells Market  

    18.5. France Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Circulating Tumor Cells Market  

    19.9. Italy Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Circulating Tumor Cells Market  

    20.13. Spain Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Circulating Tumor Cells Market  

    21.1. Eastern Europe Circulating Tumor Cells Market Overview

    21.2. Eastern Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Circulating Tumor Cells Market  

    22.1. Russia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Circulating Tumor Cells Market  

    23.1. North America Circulating Tumor Cells Market Overview

    23.2. North America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Circulating Tumor Cells Market  

    24.1. USA Circulating Tumor Cells Market Overview

    24.2. USA Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Circulating Tumor Cells Market  

    25.1. Canada Circulating Tumor Cells Market Overview

    25.2. Canada Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Circulating Tumor Cells Market  

    26.1. South America Circulating Tumor Cells Market Overview

    26.2. South America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Circulating Tumor Cells Market  

    27.1. Brazil Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Circulating Tumor Cells Market  

    28.1. Middle East Circulating Tumor Cells Market Overview

    28.2. Middle East Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Circulating Tumor Cells Market  

    29.1. Africa Circulating Tumor Cells Market Overview

    29.2. Africa Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Circulating Tumor Cells Market Competitive Landscape And Company Profiles

    30.1. Circulating Tumor Cells Market Competitive Landscape

    30.2. Circulating Tumor Cells Market Company Profiles

    30.2.1. Precision Medicine Group LLC

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Bio-Techne Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. BIOCEPT Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Creativ MicroTech Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Fluxion Biosciences Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Circulating Tumor Cells Market Competitive Benchmarking

    32. Global Circulating Tumor Cells Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

    34. Circulating Tumor Cells Market Future Outlook and Potential Analysis

    34.1 Circulating Tumor Cells Market In 2028 - Countries Offering Most New Opportunities

    34.2 Circulating Tumor Cells Market In 2028 - Segments Offering Most New Opportunities

    34.3 Circulating Tumor Cells Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Precision Medicine Group LLC Financial Performance
  • Table 76: Bio-Techne Corporation Financial Performance
  • Table 77: BIOCEPT Inc. Financial Performance
  • Table 78: Creativ MicroTech Inc. Financial Performance
  • Table 79: Fluxion Biosciences Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Precision Medicine Group LLC Financial Performance
  • Figure 76: Bio-Techne Corporation Financial Performance
  • Figure 77: BIOCEPT Inc. Financial Performance
  • Figure 78: Creativ MicroTech Inc. Financial Performance
  • Figure 79: Fluxion Biosciences Inc. Financial Performance
Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies
Read More
Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company
Read More
What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?
Read More
How Will The Laryngoscope Market Grow In 2022?
Read More
The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth
Read More
Cardiovascular Devices Global Market Report 2024 – By Type (Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Surgery Devices And Equipment Global Market Report 2024 – By Product Type (Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables), By Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications), By End User (Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Spinal Surgery Devices And Equipment Global Market Report 2024 – By Product Type (Non-Fusion Devices, Fusion Devices, Equipment), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Orthopedic And Spine Centers), By Type Of Surgery (Open Surgery And Minimally Invasive Surgery (MIS)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Handheld Surgical Devices And Equipment Global Market Report 2024 – By Product (Scalpels, Forceps, Retractor, Dilators, Graspers, Other Products), By Application, Neurosurgery, Cardiovascular, Orthopedic, Plastic & Reconstructive Surgery, Obstetrics & Gynecology, Other Applications), By End-User (Hospitals, Specialized Clinics, Long-Term Care Centers, Ambulatory Surgery Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neurosurgery Devices And Equipment Global Market Report 2024 – By Device Type (Neuroendoscope, Stereotactic Systems, Aneurysm Clips, Neurostimulation Devices, Cerebrospinal Fluid Management Devices, Neurosurgical Evacuation Device, Neurosurgical Navigation Systems, Neurosurgery Surgical Power Tools, Others (Ultrasonic Aspirators, Surgical Instruments)), By Surgery Type (Intracranial Surgery, Endonasal Neurosurgery, Spinal Surgery), By End User (Hospitals, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Robotic Surgery Devices Global Market Report 2024 – By Product (Robotic systems, Instruments & Accessories, Services), By Application (General Surgery, Urological Surgery, Gynecological Surgery, Orthopaedics Surgery, Neurosurgery And Other Applications), By End-Use (Hospitals And Ambulatory Surgery Centers (Ascs)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Electrosurgical Devices And Equipment Global Market Report 2024 – By Product (Electrosurgery Generators, Electrosurgery Instruments & Accessories, Argon and Smoke Management Systems ), By Application (General Surgery, Gynecology Surgery, Urologic Surgery, Orthopedic Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery), By End User (Hospitals, Specialized Clinics, Ambulatory Surgery Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
ENT Surgical Devices And Equipment Global Market Report 2024 – By Product (Hand Instrument, ENT Surgical Lasers, Powered ENT Surgical Systems, Radiofrequency Electrosurgical Devices, ENT Surgery Workstations, ENT Surgical Navigation System, ENT Visualization System, Surgical Microscopes), By Modality (Hand-held devices, Portable devices, Fixed devices), By End User (Hospitals, Ambulatory surgical centers, ENT Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the circulating tumor cells market?

Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer. For further insights on the circulating tumor cells market, request a sample here

How will the circulating tumor cells market drivers and restraints affect the circulating tumor cells market dynamics? What forces will shape the circulating tumor cells industry going forward?

The circulating tumor cells market major growth driver - rising cancer incidence drives surge in circulating tumor cells market. For further insights on the circulating tumor cells market, request a sample here

What is the forecast market size or the forecast market value of the circulating tumor cells market ?

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $10.79 billion in 2023 to $12.21 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to cancer incidence and prevalence, clinical utility in cancer staging, emergence of liquid biopsy, patient demand for minimally invasive tests, regulatory support for liquid biopsies, focus on early cancer detection.. The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $19.45 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to point-of-care ctc testing, adoption of microfluidics, focus on rare cancer types, standardization of ctc assays, expansion of ctc-based clinical trials, economic and emerging market growth.. Major trends in the forecast period include innovations in ctc isolation techniques, government funding for ctc research, advancements in ctc detection technologies, liquid biopsy for cancer monitorin, integration with single-cell analysis, technological convergence with artificial intelligence (ai).. For further insights on the circulating tumor cells market, request a sample here

How is the circulating tumor cells market segmented?

The circulating tumor cells market is segmented
1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, ResearchFor further insights on the circulating tumor cells market, request a sample here

Which region has the largest share of the circulating tumor cells market? What are the other regions covered in the report?

North America was the largest region in the circulating tumor cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the circulating tumor cells market, request a sample here.

Who are the major players in the circulating tumor cells market?

Major companies operating in the circulating tumor cells market report are Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd. . For further insights on the circulating tumor cells market, request a sample here.

What are the key trends in the circulating tumor cells market?

Major trend in the circulating tumor cells market - the surge of product innovations in the circulating tumor cells market. For further insights on the circulating tumor cells market, request a sample here.

What are the major opportunities in the circulating tumor cells market? What are the strategies for the circulating tumor cells market?

For detailed insights on the major opportunities and strategies in the circulating tumor cells market, request a sample here.

How does the circulating tumor cells market relate to the overall economy and other similar markets?

For detailed insights on circulating tumor cells market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the circulating tumor cells industry?

For detailed insights on the mergers and acquisitions in the circulating tumor cells industry, request a sample here.

What are the key dynamics influencing the circulating tumor cells market growth? SWOT analysis of the circulating tumor cells market.

For detailed insights on the key dynamics influencing the circulating tumor cells market growth and SWOT analysis of the circulating tumor cells industry, request a sample here.